Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation

Leuk Lymphoma. 2019 Dec;60(14):3569-3572. doi: 10.1080/10428194.2019.1639172. Epub 2019 Jul 8.

Affiliations

¹ James P. Wilmot Cancer Center, Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY, USA.
² Meyer Cancer Center, Weill Cornell Medicine and New York-Presbyterian Hospital, Department of Medicine, New York, NY, USA.
³ Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

PMID: 31282781
DOI: 10.1080/10428194.2019.1639172

No abstract available

Publication types

Letter

MeSH terms

Aged
Clinical Trials as Topic / standards*
Disease Progression
Female
Follow-Up Studies
Humans
Lymphoma, Large B-Cell, Diffuse / pathology*
Lymphoma, Large B-Cell, Diffuse / therapy*
Male
Middle Aged
Patient Selection*
Prognosis
Research Design / standards*
Retrospective Studies